Sucroferric Oxyhydroxide
1 NDC across 1 manufacturer|0 Generic,1 Brand
Sucroferric Oxyhydroxide is used to treat hyperphosphatemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $438 million on Sucroferric Oxyhydroxide across 157,000 claims for 38,000 beneficiaries.
Sucroferric Oxyhydroxide is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $17.11 to $17.11 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$17.11 – $17.11
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing SUCROFERRIC OXYHYDROXIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VELPHORO 500 MG CHEWABLE TAB | $17.1055 per EA | — |
Frequently Asked Questions
What is Sucroferric Oxyhydroxide used to treat?
Sucroferric Oxyhydroxide is used to treat hyperphosphatemia, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Sucroferric Oxyhydroxide?
In 2024, Medicare Part D spent $438 million on Sucroferric Oxyhydroxide across 157,000 claims for 38,000 beneficiaries.
How many Sucroferric Oxyhydroxide products are on the market?
The Sucroferric Oxyhydroxide drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Sucroferric Oxyhydroxide?
NADAC reference prices for Sucroferric Oxyhydroxide range from $17.1055 to $17.1055 per EA.
Which manufacturers make Sucroferric Oxyhydroxide?
1 manufacturer lists Sucroferric Oxyhydroxide in NADAC. Ranked by number of NDCs, the largest are Fresenius Medical Care Renal Therapies Group, LLC (1).